Loading…
Dividends declared (per SOCE filings): FY2017 0 · FY2018 0 · FY2019 0
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2022 annual report, the company provides cardiology clinic services. Founded 20 January 2005.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 61.0% | 61.1% | 27.8% | 83.5% | 78.0% |
| EBITDA Margin | -10.6% | -25.5% | -283.4% | 1.6% | 3.9% |
| EBITDAR | -93 | -382 | -1,004 | 7 | 61 |
| EBITDAR Margin | -5.2% | -17.5% | -254.3% | 1.6% | 4.4% |
| EBIT Margin | -10.6% | -30.4% | -283.4% | -24.2% | -5.0% |
| Net Profit Margin | -18.6% | -30.1% | -300.1% | 27.7% | 8.3% |
| Operating Expense % of Sales | 71.6% | 86.6% | 311.2% | 82.0% | 74.1% |
| Returns | |||||
| Return on Assets (ROA) | -19.0% | -26.5% | -84.2% | 8.3% | 4.6% |
| Return on Equity (ROE) | N/A | N/A | N/A | N/A | N/A |
| ROIC [EBIT / Invested Capital] | -17.5% | -68.4% | -987.6% | N/A | -224.8% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 93.8% | 88.3% | 166.6% | 93.6% | 78.1% |
| Debt-to-Equity | -2.98x | -1.81x | -1.06x | -0.70x | -1.02x |
| Debt-to-EBITDA | N/A | N/A | N/A | 200.57x | 36.31x |
| Equity-to-Assets | -31.4% | -48.8% | -157.0% | -133.9% | -76.8% |
| Net Debt | 1,631 | 2,174 | 2,322 | 1,434 | 2,009 |
| Cash & Equivalents | 9 | 10 | 22 | 16 | 1 |
| Total Debt | 1,640 | 2,185 | 2,344 | 1,451 | 2,010 |
| Liquidity & working capital | |||||
| Current Ratio | 0.80x | 0.73x | 0.25x | 0.02x | 0.41x |
| Quick Ratio | 0.69x | 0.68x | 0.21x | 0.02x | 0.41x |
| Cash Ratio | 0.01x | 0.01x | 0.02x | 0.00x | 0.00x |
| Total Current Assets | 775 | 1,241 | 298 | 427 | 945 |
| Total Current Liabilities | 966 | 1,690 | 1,173 | 18,572 | 2,293 |
| Inventory | 113 | 86 | 51 | N/A | N/A |
| Trade Receivables | 641 | 1,132 | 237 | 351 | 709 |
| Trade Payables | 581 | 1,321 | 668 | 1,367 | 1,431 |
| Net Working Capital | -191 | -449 | -875 | -18,145 | -1,347 |
| Net Working Capital % of Revenue | -10.7% | -20.6% | -221.6% | -3924.9% | -95.6% |
| Trade Working Capital | 173 | -103 | -380 | -1,016 | -722 |
| Trade Working Capital % of Revenue | 9.7% | -4.7% | -96.2% | -219.8% | -51.2% |
| Change in Trade Working Capital | N/A | -277 | -276 | -636 | 294 |
| Turnover & efficiency | |||||
| Inventory Turnover | 6.18x | 9.85x | 5.60x | N/A | N/A |
| Days Inventory Outstanding (DIO) | 59.1 | 37.0 | 65.2 | N/A | N/A |
| Receivables Turnover | 2.79x | 1.93x | 1.67x | 1.32x | 1.99x |
| Days Sales Outstanding (DSO) | 131.0 | 189.5 | 219.0 | 277.0 | 183.8 |
| Payables Turnover | 1.20x | 0.64x | 0.43x | 0.06x | 0.22x |
| Days Payable Outstanding (DPO) | 304.5 | 568.7 | 854.5 | 6547.2 | 1687.0 |
| Cash Conversion Cycle | -114.4 days | -342.2 days | -570.3 days | -6270.2 days | -1503.2 days |
| Asset Turnover | 1.02x | 0.88x | 0.28x | 0.30x | 0.55x |
| Cash flow & dividends | |||||
| Operating Cash Flow | -30 | 2 | 5 | 133 | 519 |
| Free Cash Flow (OCF − Capex proxy) | -30 | 2 | 5 | 133 | 519 |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | 1845.7% | 938.4% |
| Dividends Declared | 0 | 0 | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →